News & Articles

Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine

Focusing on innate immunity opens way for precision medicine approaches to AD

New events to provide valuable content and practical solutions to boost experimental success within chemistry labs

The combined offering is designed to provide researchers with high quality tools to diagnose cancer and selected genetic disease

Eight-marker panel, including new long mononucleotide repeat (LMR) markers, enables broader view of mismatch repair deficiency

Researchers have developed a system to identify drugs that might be repurposed to fight the coronavirus in elderly patients

Increasing Portuguese market presence by enhancing sales and after-sales support networks

RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in viral entry, and is therefore expected to be effective against emerging viral variants with mutations in the spike protein

Inspired by decades-old MIT research, the new technology could boost quantum computers and other superconducting electronics.

AstraZeneca, Exactmer, Novartis and UK Research & Innovation aim to make the UK the first country in the world to deliver this pioneering production process at a large scale

Scripting services streamline automated liquid handler performance and user convenience

Investment by Kester Capital will drive commercial growth and the development of new products to improve speed, efficiency, and productivity of the discovery process